ORLANDO, FL USA (UroToday.com) - In this poster, Dr. Michael Gorin presented quality of life outcomes from the Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) registry. This goal of the registry is to assess the safety of active surveillance (AS) for small renal masses, 4cm or smaller, and currently includes 454 patients – 188 AS patients, 265 patients undergoing primary intervention and 21 patients crossing over from AS to intervention.

auaIn the context of the increasing importance of patient perception of quality of life (QOL) and quality of care under the Affordable Care Act, this study aimed to evaluate the effect of active surveillance on patient QOL. The study used the SF12 questionnaire as its QOL assessment tool, which allows for separation of perception of QOL into mental and physical components. A total of 1 028 SF12 questionnaires were completed with a median follow up of 1 year.

The authors found that patients undergoing immediate intervention had higher QOL scores at baseline and up to 1 year after enrollment compared to those managed with AS. This difference was attributable to a baseline difference between the groups with regards to pre-existing co-morbidities, as patients undergoing AS had more co-morbidities at baseline, which resulted in lower QOL scores in the physical domain. There was no difference in the mental health scores for QOL between the AS and intervention groups after 6 months post-enrollment suggesting that AS does not result in significant increases in anxiety, depression, or other mental health issues. Interestingly mental health QOL scores were found to increase slightly over time in the AS group.

Presented by Michael Gorin at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

The James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD USA

Written by Timothy Ito, MD, medical writer for UroToday.com



Upcoming urology industry events
April 27-29, 2018 / European Society for Medical Oncology Update for Practising Oncologists
European Society for Medical Oncology Update for Practising Oncologists
May 14, 2018 / InterContinental Mark Hopkins Hotel
SITC Cancer Immune Responsiveness Workshop
May 16-17, 2018 / InterContinental Mark Hopkins Hotel
SITC Immuno-Oncology Biomarkers: State of the Art Workshop
May 17, 2018 / Moscone Convention Center North/South, San Francisco, CA
SAU 2018 Annual Meeting at the AUA
Print publications focusing on urological cancer treatments through original commentary & articles

Everyday Urology™ - Oncology Insights

From the Editor

Prostate Cancer and Prostatic Diseases

From the Editor